At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
Speaker: Michael Donio, Eurofins Discovery Services
Michael Donio from Eurofins Discovery Services, St Charles MO, presents how the IonFlux HT was validated as an instrument to screen drugs against the GABA(A) receptor. He presents assay development and drug applications data as well as statistics showing the capabilities of the IonFlux HT in their CRO business. The webinar was presented in 2014 as part of the Molecular Devices Ion Channels Webinar series.